UPDATE: JPMorgan Downgrades Five Prime Therapeutics (FPRX) to Underweight
Tweet Send to a Friend
(Updated - February 28, 2020 4:33 AM EST)
(updating comment)JPMorgan analyst Eric Joseph downgraded Five Prime Therapeutics (NASDAQ: FPRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)JPMorgan analyst Eric Joseph downgraded Five Prime Therapeutics (NASDAQ: FPRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
